Uncategorized

Innate Pharma SA announced that members of its senior management team are scheduled to participate in the following upcoming conferences.

Guardant Health, Inc., a leading precision oncology company, announced the pricing of an upsized underwritten public offering of 12,500,000 shares of its common stock at a public offering price of $28.00 per share, before deducting underwriting discounts and commissions.

Agile Therapeutics, Inc., a women’s healthcare company, announced the pricing of its public offering of an aggregate of 1,896,286 shares of its common stock, together with accompanying common stock warrants, at a public offering price of $3.9551 per share and accompanying warrants.

Data from a Phase III trial of apraglutide for a type of short bowel syndrome with intestinal failure is expected by the end of the year. It is also in a Phase II study for acute graft-versus-host disease.

Los pasos básicos para su abordaje en Atención Primaria y Emergencias

A series of recent innovations in pacemaker technology have opened up new markets and set the stage for increased competition.

John Mazzola will oversee operations as Vicarious prepares to seek FDA approval for a robotic surgery system that would take on Intuitive Surgical’s market-leading da Vinci robot.

The online pharmacy said the attack exposed customers’ email addresses, prescription information and contact details for their prescribing provider. Around 3,600 affected accounts included prescription information.

A series of recent innovations in pacemaker technology have opened up new markets and set the stage for increased competition.

Beta Bionics’ device, aimed at people with Type 1 diabetes, has eliminated most of the data entry required by competitors.